Erythromycin Ethylsuccinate
Brand names,
Erythromycin Ethylsuccinate
Analogs
Erythromycin Ethylsuccinate
Brand Names Mixture
Erythromycin Ethylsuccinate
Chemical_Formula
C9H13NO2
Erythromycin Ethylsuccinate
RX_link
No information avaliable
Erythromycin Ethylsuccinate
fda sheet
Erythromycin Ethylsuccinate
msds (material safety sheet)
Erythromycin Ethylsuccinate
Synthesis Reference
No information avaliable
Erythromycin Ethylsuccinate
Molecular Weight
167.205 g/mol
Erythromycin Ethylsuccinate
Melting Point
96 oC
Erythromycin Ethylsuccinate
H2O Solubility
2500 mg/L
Erythromycin Ethylsuccinate
State
Solid
Erythromycin Ethylsuccinate
LogP
1.514
Erythromycin Ethylsuccinate
Dosage Forms
No information avaliable
Erythromycin Ethylsuccinate
Indication
Used for the short-term treatment of insomnia, however, it generally has been replaced by other sedative-hypnotic agents.
Erythromycin Ethylsuccinate
Pharmacology
Ethinamate is used to treat insomnia (trouble in sleeping). However, it has generally been replaced by other medicines for the treatment of insomnia. If ethinamate is used regularly (for example, every day) to help produce sleep, it is usually not effective for more than 7 days. Structurally, it does not resemble the barbiturates, but it shares many effects with this class of drugs; the depressant effects of ethinamate are, however, generally milder than those of most barbiturates. Continued and inappropriate use of ethinamate can lead to tolerance and physical dependence, with withdrawal symptoms very similar to those of the barbiturates.
Erythromycin Ethylsuccinate
Absorption
Rapidly absorbed following oral administration.
Erythromycin Ethylsuccinate
side effects and Toxicity
Symptoms of overdose include shortness of breath or slow or troubled breathing, slow heartbeat, severe weakness, chronic confusion, slurred speech, and staggering.
Erythromycin Ethylsuccinate
Patient Information
Erythromycin Ethylsuccinate
Organisms Affected
Humans and other mammals